Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Intellia Therapeutics, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Intellia Therapeutics, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Intellia Therapeutics, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
$
NTLA
Intellia Therapeutics, Inc.
CIK:
0001652130
|
SEC Filings
ARTICLES AND BYLAWS
EX-3.1
ntla-ex31_156.htm
2020-05-07T00:00:00Z
EX-3.1
ntla-ex31_6.htm
2020-04-09T00:00:00Z
EX-3.1
d65395dex31.htm
2026-04-10T00:00:00Z
EX-3.1
ntla-ex3_1.htm
2026-02-26T00:00:00Z
EX-3.1
d901196dex31.htm
2025-04-07T00:00:00Z
EX-3.1
d194360dex31.htm
2016-05-17T00:00:00Z
EX-3.2
d194360dex32.htm
2016-05-17T00:00:00Z
EX-3.1
d67753dex31.htm
2016-04-27T00:00:00Z
EX-3.1
d67753dex31.htm
2016-04-11T00:00:00Z
EX-3.2
d67753dex32.htm
2016-04-11T00:00:00Z
EX-3.4
d67753dex34.htm
2016-04-11T00:00:00Z
EX-3.3
d67753dex33.htm
2016-04-11T00:00:00Z
EX-3.1
ntla-ex3_1.htm
2025-02-27T00:00:00Z
EX-3.1
ntla-ex3_1.htm
2024-06-13T00:00:00Z
EX-3.1
ntla-ex3_1.htm
2024-02-22T00:00:00Z
EX-3.1
ntla-ex3_1.htm
2023-06-16T00:00:00Z